AARDVARK THERAPEUTICS, INC. (AARD)
Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS
Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS
PicS N.V. (PICS) Faces Securities Class Action Related to IPO Omissions Regarding Credit Procedures and Quality - HBSS
Survey Exposes a Crisis of Avoidance in Family Caregiving
Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform
Abbott hosts conference call for second-quarter earnings
HBSS Expands Hub Group (HUBG) Investigation Following Mounting Accounting Discrepancies and Possible SEC Probe Per Analysts
Verra Mobility Corporation (VRRM) Securities Class Action Filed Amid Avis Termination Notice, CEO Departure, Internal Review of Negotiations & Handling of Confidential Information -- HBSS
Veritone, Inc. (VERI) Securities Class Action Filed After Admitting Improper Revenue Accounting - HBSS
Edge Case Conducts Independent, Comprehensive Assessment for Aurora, Setting New Bar for Autonomous Vehicle Safety Assurance
SS&C Black Diamond Wealth Solutions’ TAMP Exceeds USD 2 Billion in Assets